<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39332817</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>10</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1520-4804</ISSN><JournalIssue CitedMedium="Internet"><Volume>67</Volume><Issue>19</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>10</Day></PubDate></JournalIssue><Title>Journal of medicinal chemistry</Title><ISOAbbreviation>J Med Chem</ISOAbbreviation></Journal><ArticleTitle>Identification of Potent, Broad-Spectrum Coronavirus Main Protease Inhibitors for Pandemic Preparedness.</ArticleTitle><Pagination><StartPage>17454</StartPage><EndPage>17471</EndPage><MedlinePgn>17454-17471</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1021/acs.jmedchem.4c01404</ELocationID><Abstract><AbstractText>The COVID-19 pandemic highlights the ongoing risk of zoonotic transmission of coronaviruses to global health. To prepare for future pandemics, it is essential to develop effective antivirals targeting a broad range of coronaviruses. Targeting the essential and clinically validated coronavirus main protease (M<sup>pro</sup>), we constructed a structurally diverse M<sup>pro</sup> panel by clustering all known coronavirus sequences by M<sup>pro</sup> active site sequence similarity. Through screening, we identified a potent covalent inhibitor that engaged the catalytic cysteine of SARS-CoV-2 Mpro and used structure-based medicinal chemistry to develop compounds in the pyrazolopyrimidine sulfone series that exhibit submicromolar activity against multiple M<sup>pro</sup> homologues. Additionally, we solved the first X-ray cocrystal structure of M<sup>pro</sup> from the human-infecting OC43 coronavirus, providing insights into potency differences among compound-target pairs. Overall, the chemical compounds described in this study serve as starting points for the development of antivirals with broad-spectrum activity, enhancing our preparedness for emerging human-infecting coronaviruses.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Barkan</LastName><ForeName>David T</ForeName><Initials>DT</Initials><AffiliationInfo><Affiliation>Discovery Sciences, Novartis Biomedical Research, Cambridge, Massachusetts 02139, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garland</LastName><ForeName>Keira</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Global Discovery Chemistry, Novartis Biomedical Research, Emeryville, California 94608, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Global Discovery Chemistry, Novartis Biomedical Research, Emeryville, California 94608, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eastman</LastName><ForeName>Richard T</ForeName><Initials>RT</Initials><Identifier Source="ORCID">0000-0003-3580-380X</Identifier><AffiliationInfo><Affiliation>Global Health, Novartis Biomedical Research, Emeryville, California 94608, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hesse</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Global Discovery Chemistry, Novartis Biomedical Research, Emeryville, California 94608, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knapp</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Discovery Sciences, Novartis Biomedical Research, Emeryville, California 94608, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ornelas</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Discovery Sciences, Novartis Biomedical Research, Emeryville, California 94608, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Jenny</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Discovery Sciences, Novartis Biomedical Research, Emeryville, California 94608, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cortopassi</LastName><ForeName>Wilian Augusto</ForeName><Initials>WA</Initials><AffiliationInfo><Affiliation>Global Discovery Chemistry, Novartis Biomedical Research, Emeryville, California 94608, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Discovery Sciences, Novartis Biomedical Research, La Jolla, California 92121, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>King</LastName><ForeName>Frederick</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Discovery Sciences, Novartis Biomedical Research, La Jolla, California 92121, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jia</LastName><ForeName>Weiping</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Global Discovery Chemistry, Novartis Biomedical Research, Emeryville, California 94608, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Zachary</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Discovery Sciences, Novartis Biomedical Research, Cambridge, Massachusetts 02139, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frank</LastName><ForeName>Andreas O</ForeName><Initials>AO</Initials><Identifier Source="ORCID">0000-0002-2330-3974</Identifier><AffiliationInfo><Affiliation>Global Discovery Chemistry, Novartis Biomedical Research, Emeryville, California 94608, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Ryan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Global Health, Novartis Biomedical Research, Emeryville, California 94608, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fang</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Discovery Sciences, Novartis Biomedical Research, Emeryville, California 94608, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fuller</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Discovery Sciences, Novartis Biomedical Research, Cambridge, Massachusetts 02139, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Busby</LastName><ForeName>Scott</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Discovery Sciences, Novartis Biomedical Research, Cambridge, Massachusetts 02139, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carias</LastName><ForeName>Heidi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Discovery Sciences, Novartis Biomedical Research, Emeryville, California 94608, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Donahue</LastName><ForeName>Kristine</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-3248-7573</Identifier><AffiliationInfo><Affiliation>Discovery Sciences, Novartis Biomedical Research, Emeryville, California 94608, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tandeske</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Discovery Sciences, Novartis Biomedical Research, Emeryville, California 94608, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diagana</LastName><ForeName>Thierry T</ForeName><Initials>TT</Initials><AffiliationInfo><Affiliation>Global Health, Novartis Biomedical Research, Emeryville, California 94608, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jarrousse</LastName><ForeName>Nadine</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Global Health, Novartis Biomedical Research, Emeryville, California 94608, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moser</LastName><ForeName>Heinz</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-8013-2139</Identifier><AffiliationInfo><Affiliation>Global Discovery Chemistry, Novartis Biomedical Research, Emeryville, California 94608, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sarko</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Global Discovery Chemistry, Novartis Biomedical Research, Emeryville, California 94608, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dovala</LastName><ForeName>Dustin</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-2278-5027</Identifier><AffiliationInfo><Affiliation>Discovery Sciences, Novartis Biomedical Research, Emeryville, California 94608, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moquin</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Global Health, Novartis Biomedical Research, Emeryville, California 94608, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marx</LastName><ForeName>Vanessa M</ForeName><Initials>VM</Initials><AffiliationInfo><Affiliation>Global Discovery Chemistry, Novartis Biomedical Research, Emeryville, California 94608, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U19 AI171413</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Med Chem</MedlineTA><NlmUniqueID>9716531</NlmUniqueID><ISSNLinking>0022-2623</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.4.22.28</RegistryNumber><NameOfSubstance UI="D000086782">Coronavirus 3C Proteases</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000085683">Coronavirus Protease Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011480">Protease Inhibitors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086782" MajorTopicYN="Y">Coronavirus 3C Proteases</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="Y">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018360" MajorTopicYN="N">Crystallography, X-Ray</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000093485" MajorTopicYN="N">COVID-19 Drug Treatment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013329" MajorTopicYN="N">Structure-Activity Relationship</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000085683" MajorTopicYN="N">Coronavirus Protease Inhibitors</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D028962" MajorTopicYN="N">Coronavirus OC43, Human</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020134" MajorTopicYN="N">Catalytic Domain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011480" MajorTopicYN="N">Protease Inhibitors</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000096763" MajorTopicYN="N">Pandemic Preparedness</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors
declare no competing financial interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>13</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>19</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39332817</ArticleId><ArticleId IdType="pmc">PMC11472307</ArticleId><ArticleId IdType="doi">10.1021/acs.jmedchem.4c01404</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wu F.; Zhao S.; Yu B.; Chen Y. M.; Wang W.; Song Z. G.; Hu Y.; Tao Z. W.; Tian J. H.; Pei Y. Y.; Yuan M. L.; Zhang Y. L.; Dai F. H.; Liu Y.; Wang Q. M.; Zheng J. J.; Xu L.; Holmes E. C.; Zhang Y. Z. A New Coronavirus Associated with Human Respiratory Disease in China. Nature 2020, 579 (7798), 265–269. 10.1038/s41586-020-2008-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2008-3</ArticleId><ArticleId IdType="pmc">PMC7094943</ArticleId><ArticleId IdType="pubmed">32015508</ArticleId></ArticleIdList></Reference><Reference><Citation>Ksiazek T. G.; Erdman D.; Goldsmith C. S.; Zaki S. R.; Peret T.; Emery S.; Tong S.; Urbani C.; Comer J. A.; Lim W.; Rollin P. E.; Dowell S. F.; Ling A.-E.; Humphrey C. D.; Shieh W.-J.; Guarner J.; Paddock C. D.; Rota P.; Fields B.; DeRisi J.; Yang J.-Y.; Cox N.; Hughes J. M.; LeDuc J. W.; Bellini W. J.; Anderson L. J. A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome. N. Engl. J. Med. 2003, 348 (20), 1953–1966. 10.1056/NEJMoa030781.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa030781</ArticleId><ArticleId IdType="pubmed">12690092</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaki A. M.; van Boheemen S.; Bestebroer T. M.; Osterhaus A. D. M. E.; Fouchier R. A. M. Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia. N. Engl. J. Med. 2012, 367 (19), 1814–1820. 10.1056/NEJMoa1211721.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1211721</ArticleId><ArticleId IdType="pubmed">23075143</ArticleId></ArticleIdList></Reference><Reference><Citation>Brüssow H.; Brüssow L. Clinical Evidence That the Pandemic from 1889 to 1891 Commonly Called the Russian Flu Might Have Been an Earlier Coronavirus Pandemic. Microbiol. Biotechnol. 2021, 14, 1860–1870. 10.1111/1751-7915.13889.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1751-7915.13889</ArticleId><ArticleId IdType="pmc">PMC8441924</ArticleId><ArticleId IdType="pubmed">34254725</ArticleId></ArticleIdList></Reference><Reference><Citation>Geoghegan J. L.; Duchêne S.; Holmes E. C. Comparative Analysis Estimates the Relative Frequencies of Co-Divergence and Cross-Species Transmission within Viral Families. PLoS Pathog. 2017, 13 (2), e100621510.1371/journal.ppat.1006215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006215</ArticleId><ArticleId IdType="pmc">PMC5319820</ArticleId><ArticleId IdType="pubmed">28178344</ArticleId></ArticleIdList></Reference><Reference><Citation>Daszak P.; Cunningham A. A.; Hyatt A. D. Anthropogenic Environmental Change and the Emergence of Infectious Diseases in Wildlife. Acta Trop. 2001, 78 (2), 103–116. 10.1016/S0001-706X(00)00179-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0001-706X(00)00179-0</ArticleId><ArticleId IdType="pubmed">11230820</ArticleId></ArticleIdList></Reference><Reference><Citation>Chomel B. B.; Belotto A.; Meslin F. X. Wildlife, Exotic Pets, and Emerging Zoonoses. Emerging Infect. Dis. 2007, 13 (1), 6–11. 10.3201/eid1301.060480.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1301.060480</ArticleId><ArticleId IdType="pmc">PMC2725831</ArticleId><ArticleId IdType="pubmed">17370509</ArticleId></ArticleIdList></Reference><Reference><Citation>Wacharapluesadee S.; Sintunawa C.; Kaewpom T.; Khongnomnan K.; Olival K. J.; Epstein J. H.; Rodpan A.; Sangsri P.; Intarut N.; Chindamporn A.; Suksawa K.; Hemachudha T. Group C Betacoronavirus in Bat Guano Fertilizer, Thailand. Emerging Infect. Dis. 2013, 19 (8), 1349–1351. 10.3201/eid1908.130119.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1908.130119</ArticleId><ArticleId IdType="pmc">PMC3739538</ArticleId><ArticleId IdType="pubmed">23880503</ArticleId></ArticleIdList></Reference><Reference><Citation>Joyjinda Y.; Rodpan A.; Chartpituck P.; Suthum K.; Yaemsakul S.; Cheun-Arom T.; Bunprakob S.; Olival K. J.; Stokes M. M.; Hemachudha T.; Wacharapluesadee S. First Complete Genome Sequence of Human Coronavirus HKU1 from a Nonill Bat Guano Miner in Thailand. Microbiol. Resour. Announce. 2019, 8 (6), 7–8. 10.1128/MRA.01457-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MRA.01457-18</ArticleId><ArticleId IdType="pmc">PMC6368654</ArticleId><ArticleId IdType="pubmed">30746519</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith K. M.; Anthony S. J.; Switzer W. M.; Epstein J. H.; Seimon T.; Jia H.; Sanchez M. D.; Huynh T. T.; Galland G. G.; Shapiro S. E.; Sleeman J. M.; McAloose D.; Stuchin M.; Amato G.; Kolokotronis S. O.; Lipkin W. I.; Karesh W. B.; Daszak P.; Marano N. Zoonotic Viruses Associated with Illegally Imported Wildlife Products. PLoS One 2012, 7, e2950510.1371/journal.pone.0029505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0029505</ArticleId><ArticleId IdType="pmc">PMC3254615</ArticleId><ArticleId IdType="pubmed">22253731</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones B. A.; Grace D.; Kock R.; Alonso S.; Rushton J.; Said M. Y.; McKeever D.; Mutua F.; Young J.; McDermott J.; Pfeiffer D. U. Zoonosis Emergence Linked to Agricultural Intensification and Environmental Change. Proc. Natl. Acad. Sci. U.S.A. 2013, 110 (21), 8399–8404. 10.1073/pnas.1208059110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1208059110</ArticleId><ArticleId IdType="pmc">PMC3666729</ArticleId><ArticleId IdType="pubmed">23671097</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomley F. M.; Shirley M. W. Livestock Infectious Diseases and Zoonoses. Philos. Trans. R. Soc., B 2009, 364 (1530), 2637–2642. 10.1098/rstb.2009.0133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rstb.2009.0133</ArticleId><ArticleId IdType="pmc">PMC2865087</ArticleId><ArticleId IdType="pubmed">19687034</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones K. E.; Patel N. G.; Levy M. A.; Storeygard A.; Balk D.; Gittleman J. L.; Daszak P. Global Trends in Emerging Infectious Diseases. Nature 2008, 451 (7181), 990–993. 10.1038/nature06536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature06536</ArticleId><ArticleId IdType="pmc">PMC5960580</ArticleId><ArticleId IdType="pubmed">18288193</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X.; Zhang L.; Chen S.; Ouyang H.; Ren L. Possible Targets of Pan-Coronavirus Antiviral Strategies for Emerging or Re-Emerging Coronaviruses. Microorganisms 2021, 9 (7), 147910.3390/microorganisms9071479.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9071479</ArticleId><ArticleId IdType="pmc">PMC8306356</ArticleId><ArticleId IdType="pubmed">34361915</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L.; Lin D.; Sun X.; Curth U.; Drosten C.; Sauerhering L.; Becker S.; Rox K.; Hilgenfeld R. Crystal Structure of SARS-CoV-2 Main Protease Provides a Basis for Design of Improved a-Ketoamide Inhibitors. Science 2020, 368 (6489), 409–412. 10.1126/science.abb3405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb3405</ArticleId><ArticleId IdType="pmc">PMC7164518</ArticleId><ArticleId IdType="pubmed">32198291</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Z.; Du X.; Xu Y.; Deng Y.; Liu M.; Zhao Y.; Zhang B.; Li X.; Zhang L.; Peng C.; Duan Y.; Yu J.; Wang L.; Yang K.; Liu F.; Jiang R.; Yang X.; You T.; Liu X.; Yang X.; Bai F.; Liu H.; Liu X.; Guddat L. W.; Xu W.; Xiao G.; Qin C.; Shi Z.; Jiang H.; Rao Z.; Yang H. Structure of Mpro from SARS-CoV-2 and Discovery of Its Inhibitors. Nature 2020, 582 (7811), 289–293. 10.1038/s41586-020-2223-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2223-y</ArticleId><ArticleId IdType="pubmed">32272481</ArticleId></ArticleIdList></Reference><Reference><Citation>Trauner D.; Fischer C.; Veprek N.; Peitsinis Z.; Rühmann P.; Yang C.; Spradlin J.; Dovala D.; Nomura D.; Zhang Y. De Novo Design of SARS-CoV-2 Main Protease Inhibitors. Synlett 2022, 33, 458.10.1055/a-1582-0243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1582-0243</ArticleId><ArticleId IdType="pmc">PMC8916680</ArticleId><ArticleId IdType="pubmed">35282568</ArticleId></ArticleIdList></Reference><Reference><Citation>Biering S. B.; Van Dis E.; Wehri E.; Yamashiro L. H.; Nguyenla X.; Dugast-Darzacq C.; Graham T. G. W.; Stroumza J. R.; Golovkine G. R.; Roberts A. W.; Fines D. M.; Spradlin J. N.; Ward C. C.; Bajaj T.; Dovala D.; Schulze-Gamen U.; Bajaj R.; Fox D. M.; Ott M.; Murthy N.; Nomura D. K.; Schaletzky J.; Stanley S. A. Screening a Library of FDA-Approved and Bioactive Compounds for Antiviral Activity against SARS-CoV-2. ACS Infect. Dis. 2021, 7 (8), 2337–2351. 10.1021/acsinfecdis.1c00017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsinfecdis.1c00017</ArticleId><ArticleId IdType="pubmed">34129317</ArticleId></ArticleIdList></Reference><Reference><Citation>Owen D. R.; Allerton C. M. N.; Anderson A. S.; Aschenbrenner L.; Avery M.; Berritt S.; Boras B.; Cardin R. D.; Carlo A.; Coffman K. J.; Dantonio A.; Di L.; Eng H.; Ferre R.; Gajiwala K. S.; Gibson S. A.; Greasley S. E.; Hurst B. L.; Kadar E. P.; Kalgutkar A. S.; Lee J. C.; Lee J.; Liu W.; Mason S. W.; Noell S.; Novak J. J.; Obach R. S.; Ogilvie K.; Patel N. C.; Pettersson M.; Rai D. K.; Reese M. R.; Sammons M. F.; Sathish J. G.; Singh R. S. P.; Steppan C. M.; Stewart A. E.; Tuttle J. B.; Updyke L.; Verhoest P. R.; Wei L.; Yang Q.; Zhu Y. An Oral SARS-CoV-2 Mpro Inhibitor Clinical Candidate for the Treatment of COVID-19. Science 2021, 374 (6575), 1586–1593. 10.1126/science.abl4784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abl4784</ArticleId><ArticleId IdType="pubmed">34726479</ArticleId></ArticleIdList></Reference><Reference><Citation>Flynn J. M.; Samant N.; Schneider-Nachum G.; Barkan D. T.; Yilmaz N. K.; Schiffer C. A.; Moquin S. A.; Dovala D.; Bolon D. N. A. Comprehensive Fitness Landscape of SARS-CoV-2 Mpro Reveals Insights into Viral Resistance Mechanisms. eLife 2022, 11, e7743310.7554/eLife.77433.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.77433</ArticleId><ArticleId IdType="pmc">PMC9323007</ArticleId><ArticleId IdType="pubmed">35723575</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaqra A. M.; Zvornicanin S. N.; Huang Q. Y. J.; Lockbaum G. J.; Knapp M.; Tandeske L.; Bakan D. T.; Flynn J.; Bolon D. N. A.; Moquin S.; Dovala D.; Kurt Yilmaz N.; Schiffer C. A. Defining the Substrate Envelope of SARS-CoV-2 Main Protease to Predict and Avoid Drug Resistance. Nat. Commun. 2022, 13 (1), 355610.1038/s41467-022-31210-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-31210-w</ArticleId><ArticleId IdType="pmc">PMC9211792</ArticleId><ArticleId IdType="pubmed">35729165</ArticleId></ArticleIdList></Reference><Reference><Citation>Flynn J. M.; Huang Q. Y. J.; Zvornicanin S. N.; Schneider-Nachum G.; Shaqra A. M.; Yilmaz N. K.; Moquin S. A.; Dovala D.; Schiffer C. A.; Bolon D. N. A. Systematic Analyses of the Resistance Potential of Drugs Targeting SARS-CoV-2 Main Protease. ACS Infect. Dis. 2023, 9 (7), 1372–1386. 10.1021/acsinfecdis.3c00125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsinfecdis.3c00125</ArticleId><ArticleId IdType="pmc">PMC11161032</ArticleId><ArticleId IdType="pubmed">37390404</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman R. L.; Kania R. S.; Brothers M. A.; Davies J. F.; Ferre R. A.; Gajiwala K. S.; He M.; Hogan R. J.; Kozminski K.; Li L. Y.; Lockner J. W.; Lou J.; Marra M. T.; Mitchell L. J.; Murray B. W.; Nieman J. A.; Noell S.; Planken S. P.; Rowe T.; Ryan K.; Smith G. J.; Solowiej J. E.; Steppan C. M.; Taggart B. Discovery of Ketone-Based Covalent Inhibitors of Coronavirus 3CL Proteases for the Potential Therapeutic Treatment of COVID-19. J. Med. Chem. 2020, 63 (21), 12725–12747. 10.1021/acs.jmedchem.0c01063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jmedchem.0c01063</ArticleId><ArticleId IdType="pmc">PMC7571312</ArticleId><ArticleId IdType="pubmed">33054210</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon P.; Zammit C. M.; Shao Q.; Dovala D.; Boike L.; Henning N. J.; Knapp M.; Spradlin J. N.; Ward C. C.; Wolleb H.; Fuller D.; Blake G.; Murphy J. P.; Wang F.; Lu Y.; Moquin S. A.; Tandeske L.; Hesse M. J.; McKenna J. M.; Tallarico J. A.; Schirle M.; Toste F. D.; Nomura D. K. Discovery of Potent Pyrazoline-Based Covalent SARS-CoV-2 Main Protease Inhibitors**. ChemBioChem 2023, 24 (11), e20230011610.1002/cbic.202300116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cbic.202300116</ArticleId><ArticleId IdType="pubmed">37069799</ArticleId></ArticleIdList></Reference><Reference><Citation>Flynn J. M.; Zvornicanin S. N.; Tsepal T.; Shaqra A. M.; Kurt Yilmaz N.; Jia W.; Moquin S.; Dovala D.; Schiffer C. A.; Bolon D. N. A. Contributions of Hyperactive Mutations in Mpro from SARS-CoV-2 to Drug Resistance. ACS Infect. Dis. 2024, 10, 1174.10.1021/acsinfecdis.3c00560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsinfecdis.3c00560</ArticleId><ArticleId IdType="pmc">PMC11179160</ArticleId><ArticleId IdType="pubmed">38472113</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss S. R.; Hughes S. A.; Bonilla P. J.; Turner J. D.; Leibowitz J. L.; Denison M. R. Coronavirus Polyprotein Processing. Arch. Virol., Suppl. 1994, 9, 349–358. 10.1007/978-3-7091-9326-6_35.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-7091-9326-6_35</ArticleId><ArticleId IdType="pubmed">8032266</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H. J.; Shieh C. K.; Gorbalenya A. E.; Koonin E. V.; La Monica N.; Tuler J.; Bagdzhadzhyan A.; Lai M. M. C. The Complete Sequence (22 Kilobases) of Murine Coronavirus Gene 1 Encoding the Putative Proteases and RNA Polymerase. Virology 1991, 180 (2), 567–582. 10.1016/0042-6822(91)90071-I.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0042-6822(91)90071-I</ArticleId><ArticleId IdType="pmc">PMC7131164</ArticleId><ArticleId IdType="pubmed">1846489</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh J.; Petter R. C.; Baillie T. A.; Whitty A. The Resurgence of Covalent Drugs. Nat. Rev. Drug Discovery 2011, 10 (4), 307–317. 10.1038/nrd3410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd3410</ArticleId><ArticleId IdType="pubmed">21455239</ArticleId></ArticleIdList></Reference><Reference><Citation>Resnick S. J.; Iketani S.; Hong S. J.; Zask A.; Liu H.; Kim S.; Melore S.; Lin F.-Y.; Nair M. S.; Huang Y.; Lee S.; Tay N. E. S.; Rovis T.; Yang H. W.; Xing L.; Stockwell B. R.; Ho D. D.; Chavez A. Inhibitors of Coronavirus 3CL Proteases Protect Cells from Protease-Mediated Cytotoxicity. J. Virol. 2021, 95 (14), e023742010.1128/JVI.02374-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02374-20</ArticleId><ArticleId IdType="pmc">PMC8223961</ArticleId><ArticleId IdType="pubmed">33910954</ArticleId></ArticleIdList></Reference><Reference><Citation>Sayers E. W.; Bolton E. E.; Brister J. R.; Canese K.; Chan J.; Comeau D. C.; Connor R.; Funk K.; Kelly C.; Kim S.; Madej T.; Marchler-Bauer A.; Lanczycki C.; Lathrop S.; Lu Z.; Thibaud-Nissen F.; Murphy T.; Phan L.; Skripchenko Y.; Tse T.; Wang J.; Williams R.; Trawick B. W.; Pruitt K. D.; Sherry S. T. Database Resources of the National Center for Biotechnology Information. Nucleic Acids Res. 2022, 50 (D1), D20–D26. 10.1093/nar/gkab1112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkab1112</ArticleId><ArticleId IdType="pmc">PMC8728269</ArticleId><ArticleId IdType="pubmed">34850941</ArticleId></ArticleIdList></Reference><Reference><Citation>Olson R. D.; Assaf R.; Brettin T.; Conrad N.; Cucinell C.; Davis J. J.; Dempsey D. M.; Dickerman A.; Dietrich E. M.; Kenyon R. W.; Kuscuoglu M.; Lefkowitz E. J.; Lu J.; Machi D.; Macken C.; Mao C.; Niewiadomska A.; Nguyen M.; Olsen G. J.; Overbeek J. C.; Parrello B.; Parrello V.; Porter J. S.; Pusch G. D.; Shukla M.; Singh I.; Stewart L.; Tan G.; Thomas C.; VanOeffelen M.; Vonstein V.; Wallace Z. S.; Warren A. S.; Wattam A. R.; Xia F.; Yoo H.; Zhang Y.; Zmasek C. M.; Scheuermann R. H.; Stevens R. L. Introducing the Bacterial and Viral Bioinformatics Resource Center (BV-BRC): A Resource Combining PATRIC, IRD and ViPR. Nucleic Acids Res. 2023, 51 (1 D), D678–D689. 10.1093/nar/gkac1003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkac1003</ArticleId><ArticleId IdType="pmc">PMC9825582</ArticleId><ArticleId IdType="pubmed">36350631</ArticleId></ArticleIdList></Reference><Reference><Citation>Camacho C.; Coulouris G.; Avagyan V.; Ma N.; Papadopoulos J.; Bealer K.; Madden T. L. BLAST+: Architecture and Applications. BMC Bioinf. 2009, 10, 42110.1186/1471-2105-10-421.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-10-421</ArticleId><ArticleId IdType="pmc">PMC2803857</ArticleId><ArticleId IdType="pubmed">20003500</ArticleId></ArticleIdList></Reference><Reference><Citation>Unoh Y.; Uehara S.; Nakahara K.; Nobori H.; Yamatsu Y.; Yamamoto S.; Maruyama Y.; Taoda Y.; Kasamatsu K.; Suto T.; Kouki K.; Nakahashi A.; Kawashima S.; Sanaki T.; Toba S.; Uemura K.; Mizutare T.; Ando S.; Sasaki M.; Orba Y.; Sawa H.; Sato A.; Sato T.; Kato T.; Tachibana Y. Discovery of S-217622, a Noncovalent Oral SARS-CoV-2 3CL Protease Inhibitor Clinical Candidate for Treating COVID-19. J. Med. Chem. 2022, 65, 6499.10.1021/acs.jmedchem.2c00117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jmedchem.2c00117</ArticleId><ArticleId IdType="pmc">PMC8982737</ArticleId><ArticleId IdType="pubmed">35352927</ArticleId></ArticleIdList></Reference><Reference><Citation>Douangamath A.; Fearon D.; Gehrtz P.; Krojer T.; Lukacik P.; Owen C. D.; Resnick E.; Strain-Damerell C.; Aimon A.; Ábrányi-Balogh P.; Brandão-Neto J.; Carbery A.; Davison G.; Dias A.; Downes T. D.; Dunnett L.; Fairhead M.; Firth J. D.; Jones S. P.; Keeley A.; Keserü G. M.; Klein H. F.; Martin M. P.; Noble M. E. M.; O’Brien P.; Powell A.; Reddi R. N.; Skyner R.; Snee M.; Waring M. J.; Wild C.; London N.; von Delft F.; Walsh M. A. Crystallographic and Electrophilic Fragment Screening of the SARS-CoV-2 Main Protease. Nat. Commun. 2020, 11 (1), 504710.1038/s41467-020-18709-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18709-w</ArticleId><ArticleId IdType="pmc">PMC7542442</ArticleId><ArticleId IdType="pubmed">33028810</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomar S.; Johnston M. L.; John S. E. S.; Osswald H. L.; Nyalapatla P. R.; Paul L. N.; Ghosh A. K.; Denison M. R.; Mesecar A. D. Ligand-Induced Dimerization of Middle East Respiratory Syndrome (MERS) Coronavirus Nsp5 Protease (3CLpro): Implications for Nsp5 Regulation and the Development of Antivirals. J. Biol. Chem. 2015, 290 (32), 19403–19422. 10.1074/jbc.M115.651463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.651463</ArticleId><ArticleId IdType="pmc">PMC4528106</ArticleId><ArticleId IdType="pubmed">26055715</ArticleId></ArticleIdList></Reference><Reference><Citation>Beach J. R. A Filtrable Virus, the Cause of Infectious Laryngotracheitis of Chickens. J. Exp. Med. 1931, 54 (6), 809–816. 10.1084/jem.54.6.809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.54.6.809</ArticleId><ArticleId IdType="pmc">PMC2180297</ArticleId><ArticleId IdType="pubmed">19869961</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue X.; Yu H.; Yang H.; Xue F.; Wu Z.; Shen W.; Li J.; Zhou Z.; Ding Y.; Zhao Q.; Zhang X. C.; Liao M.; Bartlam M.; Rao Z. Structures of Two Coronavirus Main Proteases: Implications for Substrate Binding and Antiviral Drug Design. J. Virol. 2008, 82 (5), 2515–2527. 10.1128/JVI.02114-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02114-07</ArticleId><ArticleId IdType="pmc">PMC2258912</ArticleId><ArticleId IdType="pubmed">18094151</ArticleId></ArticleIdList></Reference><Reference><Citation>Chasey D.; Cartwright S. F. Virus-like Particles Associated with Porcine Epidemic Diarrhoea. Res. Vet. Sci. 1978, 25 (2), 255–256. 10.1016/S0034-5288(18)32994-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0034-5288(18)32994-1</ArticleId><ArticleId IdType="pmc">PMC7130664</ArticleId><ArticleId IdType="pubmed">103154</ArticleId></ArticleIdList></Reference><Reference><Citation>St John S. E.; Anson B. J.; Mesecar A. D. X-Ray Structure and Inhibition of 3C-like Protease from Porcine Epidemic Diarrhea Virus. Sci. Rep. 2016, 6 (1), 2596110.1038/srep25961.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep25961</ArticleId><ArticleId IdType="pmc">PMC4865815</ArticleId><ArticleId IdType="pubmed">27173881</ArticleId></ArticleIdList></Reference><Reference><Citation>McIntosh K.; Dees J. H.; Becker W. B.; Kapikian A. Z.; Chanock R. M. Recovery in Tracheal Organ Cultures of Novel Viruses from Patients with Respiratory Disease. Proc. Natl. Acad. Sci. U.S.A. 1967, 57 (4), 933–940. 10.1073/pnas.57.4.933.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.57.4.933</ArticleId><ArticleId IdType="pmc">PMC224637</ArticleId><ArticleId IdType="pubmed">5231356</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo P. C. Y.; Lau S. K. P.; Chu C.; Chan K.; Tsoi H.; Huang Y.; Wong B. H. L.; Poon R. W. S.; Cai J. J.; Luk W.; Poon L. L. M.; Wong S. S. Y.; Guan Y.; Peiris J. S. M.; Yuen K. Characterization and Complete Genome Sequence of a Novel Coronavirus, Coronavirus HKU1, from Patients with Pneumonia. J. Virol. 2005, 79 (2), 884–895. 10.1128/JVI.79.2.884-895.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.2.884-895.2005</ArticleId><ArticleId IdType="pmc">PMC538593</ArticleId><ArticleId IdType="pubmed">15613317</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Q.; Li S.; Xue F.; Zou Y.; Chen C.; Bartlam M.; Rao Z. Structure of the Main Protease from a Global Infectious Human Coronavirus, HCoV-HKU1. J. Virol. 2008, 82 (17), 8647–8655. 10.1128/JVI.00298-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00298-08</ArticleId><ArticleId IdType="pmc">PMC2519634</ArticleId><ArticleId IdType="pubmed">18562531</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang H. W.; Egberink H. F.; Halpin R.; Spiro D. J.; Rottie P. J. M. Spike Protein Fusion Peptide and Feline Coronavirus Virulence. Emerging Infect. Dis. 2012, 18 (7), 1089–1095. 10.3201/eid1807.120143.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1807.120143</ArticleId><ArticleId IdType="pmc">PMC3376813</ArticleId><ArticleId IdType="pubmed">22709821</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu L.; Ye F.; Feng Y.; Yu F.; Wang Q.; Wu Y.; Zhao C.; Sun H.; Huang B.; Niu P.; Song H.; Shi Y.; Li X.; Tan W.; Qi J.; Gao G. F. Both Boceprevir and GC376 Efficaciously Inhibit SARS-CoV-2 by Targeting Its Main Protease. Nat. Commun. 2020, 11 (1), 441710.1038/s41467-020-18233-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18233-x</ArticleId><ArticleId IdType="pmc">PMC7474075</ArticleId><ArticleId IdType="pubmed">32887884</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H.; Yang M.; Ding Y.; Liu Y.; Lou Z.; Zhou Z.; Sun L.; Mo L.; Ye S.; Pang H.; Gao G. F.; Anand K.; Bartlam M.; Hilgenfeld R.; Rao Z. The Crystal Structures of Severe Acute Respiratory Syndrome Virus Main Protease and Its Complex with an Inhibitor. Proc. Natl. Acad. Sci. U.S.A. 2003, 100 (23), 13190–13195. 10.1073/pnas.1835675100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1835675100</ArticleId><ArticleId IdType="pmc">PMC263746</ArticleId><ArticleId IdType="pubmed">14585926</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo P. C. Y.; Lau S. K. P.; Li K. S. M.; Poon R. W. S.; Wong B. H. L.; Tsoi H. wah.; Yip B. C. K.; Huang Y.; Chan K. hung.; Yuen K. yung. Molecular Diversity of Coronaviruses in Bats. Virology 2006, 351 (1), 180–187. 10.1016/j.virol.2006.02.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2006.02.041</ArticleId><ArticleId IdType="pmc">PMC7111821</ArticleId><ArticleId IdType="pubmed">16647731</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo P. C. Y.; Lau S. K. P.; Lam C. S. F.; Lau C. C. Y.; Tsang A. K. L.; Lau J. H. N.; Bai R.; Teng J. L. L.; Tsang C. C. C.; Wang M.; Zheng B.-J.; Chan K.-H.; Yuen K.-Y. Discovery of Seven Novel Mammalian and Avian Coronaviruses in the Genus Deltacoronavirus Supports Bat Coronaviruses as the Gene Source of Alphacoronavirus and Betacoronavirus and Avian Coronaviruses as the Gene Source of Gammacoronavirus and Deltacoronavi. J. Virol. 2012, 86 (7), 3995–4008. 10.1128/JVI.06540-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.06540-11</ArticleId><ArticleId IdType="pmc">PMC3302495</ArticleId><ArticleId IdType="pubmed">22278237</ArticleId></ArticleIdList></Reference><Reference><Citation>Zvornicanin S. N.; Shaqra A. M.; Huang Q. J.; Ornelas E.; Moghe M.; Knapp M.; Moquin S.; Dovala D.; Schiffer C. A.; Kurt Yilmaz N. Crystal Structures of Inhibitor-Bound Main Protease from Delta- and Gamma-Coronaviruses. Viruses 2023, 15 (3), 78110.3390/v15030781.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15030781</ArticleId><ArticleId IdType="pmc">PMC10059799</ArticleId><ArticleId IdType="pubmed">36992489</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamre D.; Procknow J. J. A New Virus Isolated from the Human Respiratory Tract. Proc. Soc. Exp Biol. Med. 1966, 121 (1), 190–193. 10.3181/00379727-121-30734.</Citation><ArticleIdList><ArticleId IdType="doi">10.3181/00379727-121-30734</ArticleId><ArticleId IdType="pubmed">4285768</ArticleId></ArticleIdList></Reference><Reference><Citation>Anand K.; Anand K.; Ziebuhr J.; Wadhwani P. Coronavirus main proteinase (3CL pro) Structure: Basis for Design of Anti-SARS Drugs. Science 2014, 1763 (2003), 1763–1768. 10.1126/science.1085658.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1085658</ArticleId><ArticleId IdType="pubmed">12746549</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Hoek L.; Pyrc K.; Jebbink M. F.; Vermeulen-Oost W.; Berkhout R. J. M.; Wolthers K. C.; Wertheim-van Dillen P. M. E.; Kaandorp J.; Spaargaren J.; Berkhout B. Identification of a New Human Coronavirus. Nat. Med. 2004, 10 (4), 368–373. 10.1038/nm1024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1024</ArticleId><ArticleId IdType="pmc">PMC7095789</ArticleId><ArticleId IdType="pubmed">15034574</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F.; Chen C.; Tan W.; Yang K.; Yang H. Structure of Main Protease from Human Coronavirus NL63: Insights for Wide Spectrum Anti-Coronavirus Drug Design. Sci. Rep. 2016, 6 (March), 2267710.1038/srep22677.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep22677</ArticleId><ArticleId IdType="pmc">PMC4780191</ArticleId><ArticleId IdType="pubmed">26948040</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo P. C. Y.; Wang M.; Lau S. K. P.; Xu H.; Poon R. W. S.; Guo R.; Wong B. H. L.; Gao K.; Tsoi H.; Huang Y.; Li K. S. M.; Lam C. S. F.; Chan K.; Zheng B.; Yuen K. Comparative Analysis of Twelve Genomes of Three Novel Group 2c and Group 2d Coronaviruses Reveals Unique Group and Subgroup Features. J. Virol. 2007, 81 (4), 1574–1585. 10.1128/JVI.02182-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02182-06</ArticleId><ArticleId IdType="pmc">PMC1797546</ArticleId><ArticleId IdType="pubmed">17121802</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin X. D.; Wang W.; Hao Z. Y.; Wang Z. X.; Guo W. P.; Guan X. Q.; Wang M. R.; Wang H. W.; Zhou R. H.; Li M. H.; Tang G. P.; Wu J.; Holmes E. C.; Zhang Y. Z. Extensive Diversity of Coronaviruses in Bats from China. Virology 2017, 507 (February), 1–10. 10.1016/j.virol.2017.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2017.03.019</ArticleId><ArticleId IdType="pmc">PMC7111643</ArticleId><ArticleId IdType="pubmed">28384506</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W.; Lin X.-D.; Liao Y.; Guan X.-Q.; Guo W.-P.; Xing J.-G.; Holmes E. C.; Zhang Y.-Z. Discovery of a Highly Divergent Coronavirus in the Asian House Shrew from China Illuminates the Origin of the Alphacoronaviruses. J. Virol. 2017, 91 (17), e00764-1710.1128/JVI.00764-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00764-17</ArticleId><ArticleId IdType="pmc">PMC5553162</ArticleId><ArticleId IdType="pubmed">28637760</ArticleId></ArticleIdList></Reference><Reference><Citation>Mihindukulasuriya K. A.; Wu G.; St Leger J.; Nordhausen R. W.; Wang D. Identification of a Novel Coronavirus from a Beluga Whale by Using a Panviral Microarray. J. Virol. 2008, 82 (10), 5084–5088. 10.1128/jvi.02722-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.02722-07</ArticleId><ArticleId IdType="pmc">PMC2346750</ArticleId><ArticleId IdType="pubmed">18353961</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi M.; Lin X.-D.; Chen X.; Tian J.-H.; Chen L.-J.; Li K.; Wang W.; Eden J.-S.; Shen J.-J.; Liu L.; Holmes E. C.; Zhang Y.-Z. The Evolutionary History of Vertebrate RNA Viruses. Nature 2018, 556 (7700), 197–202. 10.1038/s41586-018-0012-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0012-7</ArticleId><ArticleId IdType="pubmed">29618816</ArticleId></ArticleIdList></Reference><Reference><Citation>Mordecai G. J.; Miller K. M.; Di Cicco E.; Schulze A. D.; Kaukinen K. H.; Ming T. J.; Li S.; Tabata A.; Teffer A.; Patterson D. A.; Ferguson H. W.; Suttle C. A. Endangered Wild Salmon Infected by Newly Discovered Viruses. eLife 2019, 8, e4761510.7554/eLife.47615.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.47615</ArticleId><ArticleId IdType="pmc">PMC6721791</ArticleId><ArticleId IdType="pubmed">31478480</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller A. K.; Mifsud J. C. O.; Costa V. A.; Grimwood R. M.; Kitson J.; Baker C.; Brosnahan C. L.; Pande A.; Holmes E. C.; Gemmell N. J.; Geoghegan J. L. Slippery When Wet: Cross-Species Transmission of Divergent Coronaviruses in Bony and Jawless Fish and the Evolutionary History of the Coronaviridae. Virus Evol. 2021, 7 (2), veab05010.1093/ve/veab050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ve/veab050</ArticleId><ArticleId IdType="pmc">PMC8244743</ArticleId><ArticleId IdType="pubmed">34527280</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z.; Lu L.; Du J.; Yang L.; Ren X.; Liu B.; Jiang J.; Yang J.; Dong J.; Sun L.; Zhu Y.; Li Y.; Zheng D.; Zhang C.; Su H.; Zheng Y.; Zhou H.; Zhu G.; Li H.; Chmura A.; Yang F.; Daszak P.; Wang J.; Liu Q.; Jin Q. Comparative Analysis of Rodent and Small Mammal Viromes to Better Understand the Wildlife Origin of Emerging Infectious Diseases 06 Biological Sciences 0604 Genetics 11 Medical and Health Sciences 1108 Medical Microbiology. Microbiome 2018, 6 (1), 17810.1186/s40168-018-0554-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-018-0554-9</ArticleId><ArticleId IdType="pmc">PMC6171170</ArticleId><ArticleId IdType="pubmed">30285857</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu F.; Duong V.; Lim X. F.; Hul V.; Chawla T.; Keatts L.; Goldstein T.; Hassanin A.; Tu V. T.; Buchy P.; Sessions O. M.; Wang L. F.; Dussart P.; Anderson D. E. Presence of Recombinant Bat Coronavirus GCCDC1 in Cambodian Bats. Viruses 2022, 14 (2), 17610.3390/v14020176.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14020176</ArticleId><ArticleId IdType="pmc">PMC8877364</ArticleId><ArticleId IdType="pubmed">35215769</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson T. W.; Gallego R. A.; Edwards M. P. Lipophilic Efficiency as an Important Metric in Drug Design. J. Med. Chem. 2018, 61 (15), 6401–6420. 10.1021/acs.jmedchem.8b00077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jmedchem.8b00077</ArticleId><ArticleId IdType="pubmed">29589935</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakhno Y. I.; Murlykina M. V.; Zbruyev O. I.; Kozyryev A. V.; Shishkina S. V.; Sysoiev D.; Musatov V. I.; Desenko S. M.; Chebanov V. A. Ultrasonic-Assisted Unusual Four-Component Synthesis of 7-Azolylamino-4,5,6,7-Tetrahydroazolo[1,5-a]Pyrimidines. Beilstein J. Org. Chem. 2020, 16, 281–289. 10.3762/bjoc.16.27.</Citation><ArticleIdList><ArticleId IdType="doi">10.3762/bjoc.16.27</ArticleId><ArticleId IdType="pmc">PMC7059450</ArticleId><ArticleId IdType="pubmed">32180844</ArticleId></ArticleIdList></Reference><Reference><Citation>Chebanov V. A.; Sakhno Y. I.; Desenko S. M.; Chernenko V. N.; Musatov V. I.; Shishkina S. V.; Shishkin O. V.; Kappe C. O. Cyclocondensation Reactions of 5-Aminopyrazoles, Pyruvic Acids and Aldehydes. Multicomponent Approaches to Pyrazolopyridines and Related Products. Tetrahedron 2007, 63 (5), 1229–1242. 10.1016/j.tet.2006.11.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tet.2006.11.048</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel A. S.; Kapuriya N. P.; Naliapara Y. T. A Concise [3 + 3] Heteroaromatization Synthetic Strategy Afford Dicarboxamide Functionalized Novel Pyrazolo[1,5-a]Pyrimidines. J. Heterocycl. Chem. 2017, 54 (5), 2635–2643. 10.1002/jhet.2860.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jhet.2860</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas A.; Chakraborty M.; Ila H.; Junjappa H. Cyclocondensation of Oxoketene Dithioacetals with 3-Aminopyrazoles: A Facile Highly Regioselective General Route to Substituted and Fused Pyrazolo]Pyrimidines. Tetrahedron 1990, 46 (2), 577–586. 10.1016/S0040-4020(01)85438-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0040-4020(01)85438-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Geraghty R. J.; Aliota M. T.; Bonnac L. F. Broad-Spectrum Antiviral Strategies and Nucleoside Analogues. Viruses 2021, 13 (4), 66710.3390/v13040667.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13040667</ArticleId><ArticleId IdType="pmc">PMC8069527</ArticleId><ArticleId IdType="pubmed">33924302</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertani G. Studies on Lysogenesis. I. The Mode of Phage Liberation by Lysogenic Escherichia Coli. J. Bacteriol. 1951, 62, 293–300. 10.1128/jb.62.3.293-300.1951.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jb.62.3.293-300.1951</ArticleId><ArticleId IdType="pmc">PMC386127</ArticleId><ArticleId IdType="pubmed">14888646</ArticleId></ArticleIdList></Reference><Reference><Citation>Tartof K. D. Improved Media for Growing Plasmid and Cosmid Clones. Bethesda Res. Lab. Focus. 1987, 9, 12.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>